BNY Mellon Research Growth Fund Q2 2025 Commentary
BNY Mellon Research Growth Fund Q2 2025 Commentary
Source link
Similar Posts
Here Are My Top 2 Undervalued Stocks to Buy Right Now
Despite the market still running at near highs, there are still some superb undervalued stocks to buy right now. Not only do these come in at a discounted price, but they also come with superb growth and income potential. Here’s a look at some of those great undervalued stocks to consider adding to your portfolio….
Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
Outlook Therapeutics NASDAQ: OTLK has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target. OTLK Outlook Therapeutics $7.07 -0.49 (-6.48%) (As of 06/18/2024 ET) 52-Week Range $4.00 ▼ $37.00 Price Target $46.43 It’s essential to remember that low-float biopharmaceutical companies often experience volatility due to frequent breaking news and…
Coursera: A Merger With Udemy Cannot Offset AI Concerns (NYSE:COUR)
This article was written by Follow The Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events. As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports…
Autonomous truck company Aurora delays hauling freight without human drivers until April
PITTSBURGH (AP) — Autonomous truck company Aurora Innovation says it won’t start hauling freight without humans on board until April of next year, a delay from previous statements that commercial service would begin by the end of 2024. Get analyst upgrade alerts: Sign Up The Pittsburgh company on Wednesday said the April launch of driverless…
